{"schema_version":"secwatch.filing_event.v1","accession":"0000950103-24-006675","form_type":"8-K","ticker":"PGEN","cik":"0001356090","company_name":"PRECIGEN, INC.","filed_at":"2024-05-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.069915+00:00","generated_at":"2026-06-02T00:31:42.887246+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Precigen Q1 net loss $23.7M, revenue down 43%; PRGN-2012 BLA submission on track for H2 2024","bullets":["Net loss $23.7M ($0.10 EPS) vs $22.7M; total revenue down 43% YoY to approx. $1.06M.","Cash, equivalents, and short-term investments $44.8M; evaluating financing options to strengthen balance sheet.","PRGN-2012 pivotal Phase 2 data as late-breaking oral at ASCO June 3; rolling BLA submission expected H2 2024.","Commercial readiness activities underway for potential PRGN-2012 launch in 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0000950103-24-006675","json":"https://secwatch.observer/filing/0000950103-24-006675.json","markdown":"https://secwatch.observer/filing/0000950103-24-006675.md","text":"https://secwatch.observer/filing/0000950103-24-006675.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1356090/000095010324006675/0000950103-24-006675-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1356090/000095010324006675/dp211199_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T00:31:42.887246+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"416e81266d6d0a5cccfc68006fa60146e81eff70","claim":"PRECIGEN, INC. reported financial results for first quarter 2024.","evidence_excerpt":"Attached as Exhibit 99.1 is a copy of a press release of Precigen, Inc., dated May 14, 2024, reporting its financial results for the quarter ended March 31, 2024.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1356090/000095010324006675/0000950103-24-006675-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter 2024"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}